Trials / Completed
CompletedNCT00455442
A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain
A Two-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Corcept Therapeutics · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This is a two-week study testing the efficacy and safety of mifepristone in the prevention of olanzapine-induced weight gain in healthy male volunteers by measuring changes in body weight and BMI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mifepristone |
Timeline
- Start date
- 2007-03-01
- Completion
- 2007-07-01
- First posted
- 2007-04-03
- Last updated
- 2008-09-19
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT00455442. Inclusion in this directory is not an endorsement.